Maple Capital Management Inc. Grows Position in Colgate-Palmolive Company $CL

Maple Capital Management Inc. grew its holdings in Colgate-Palmolive Company (NYSE:CL) by 5.8% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 173,632 shares of the company’s stock after buying an additional 9,555 shares during the period. Maple Capital Management Inc.’s holdings in Colgate-Palmolive were worth $13,880,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently modified their holdings of the business. S.A. Mason LLC raised its holdings in Colgate-Palmolive by 3.9% in the 3rd quarter. S.A. Mason LLC now owns 3,499 shares of the company’s stock valued at $280,000 after acquiring an additional 130 shares during the last quarter. Security National Bank of Sioux City Iowa IA grew its position in shares of Colgate-Palmolive by 0.8% in the third quarter. Security National Bank of Sioux City Iowa IA now owns 16,241 shares of the company’s stock valued at $1,298,000 after purchasing an additional 130 shares in the last quarter. Stratos Wealth Advisors LLC grew its position in shares of Colgate-Palmolive by 4.5% in the third quarter. Stratos Wealth Advisors LLC now owns 3,015 shares of the company’s stock valued at $241,000 after purchasing an additional 130 shares in the last quarter. Cordatus Wealth Management LLC increased its holdings in shares of Colgate-Palmolive by 0.6% in the second quarter. Cordatus Wealth Management LLC now owns 23,036 shares of the company’s stock valued at $2,094,000 after purchasing an additional 134 shares during the last quarter. Finally, Chicago Partners Investment Group LLC lifted its position in Colgate-Palmolive by 1.5% during the third quarter. Chicago Partners Investment Group LLC now owns 9,387 shares of the company’s stock worth $724,000 after buying an additional 136 shares in the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Colgate-Palmolive

In other news, COO Panagiotis Tsourapas sold 15,000 shares of the business’s stock in a transaction that occurred on Thursday, February 12th. The shares were sold at an average price of $97.81, for a total value of $1,467,150.00. Following the sale, the chief operating officer directly owned 10,415 shares of the company’s stock, valued at approximately $1,018,691.15. The trade was a 59.02% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Sally Massey sold 15,851 shares of the company’s stock in a transaction that occurred on Thursday, February 5th. The stock was sold at an average price of $95.03, for a total transaction of $1,506,320.53. Following the completion of the transaction, the insider owned 13,751 shares in the company, valued at approximately $1,306,757.53. This represents a 53.55% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 184,683 shares of company stock valued at $17,486,693 in the last ninety days. Insiders own 0.41% of the company’s stock.

Colgate-Palmolive Price Performance

NYSE:CL opened at $89.90 on Wednesday. Colgate-Palmolive Company has a 52 week low of $74.54 and a 52 week high of $99.33. The stock’s fifty day moving average is $90.64 and its two-hundred day moving average is $83.31. The company has a market capitalization of $72.47 billion, a P/E ratio of 34.31, a P/E/G ratio of 4.04 and a beta of 0.28. The company has a quick ratio of 0.54, a current ratio of 0.83 and a debt-to-equity ratio of 18.82.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. The business had revenue of $5.23 billion during the quarter, compared to analysts’ expectations of $5.13 billion. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The company’s revenue was up 5.8% compared to the same quarter last year. During the same period in the prior year, the business posted $0.91 EPS. Equities analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Monday, April 20th will be paid a dividend of $0.53 per share. This represents a $2.12 annualized dividend and a yield of 2.4%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.52. The ex-dividend date of this dividend is Monday, April 20th. Colgate-Palmolive’s payout ratio is 79.39%.

Analysts Set New Price Targets

CL has been the subject of several analyst reports. Evercore upped their target price on Colgate-Palmolive from $94.00 to $100.00 and gave the company an “outperform” rating in a report on Monday, February 2nd. The Goldman Sachs Group reiterated a “buy” rating and set a $100.00 price target on shares of Colgate-Palmolive in a report on Friday, February 20th. JPMorgan Chase & Co. boosted their price target on shares of Colgate-Palmolive from $93.00 to $97.00 and gave the company an “overweight” rating in a research report on Monday, February 2nd. Wells Fargo & Company upped their price objective on shares of Colgate-Palmolive from $86.00 to $94.00 and gave the company an “equal weight” rating in a report on Sunday, February 1st. Finally, Royal Bank Of Canada upgraded shares of Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 price objective for the company in a research report on Tuesday, December 9th. Eleven research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat, Colgate-Palmolive presently has an average rating of “Moderate Buy” and a consensus target price of $94.75.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.